LPCN: Lipocine Inc. Stock

by  •  • Comments Off on LPCN: Lipocine Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.79
Enterprise Value ($M) 26.71
Book Value ($M) 23.96
Book Value / Share 4.48
Price / Book 1.24
NCAV ($M) 23.83
NCAV / Share 4.45
Price / NCAV 1.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.31

Liquidity (mrq)
Quick Ratio 16.99
Current Ratio 16.99

Balance Sheet (mrq) ($M)
Current Assets 25.32
Assets 25.45
Liabilities 1.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue -2.85
Operating Income -17.93
Net Income -16.35
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.87
Cash from Investing 13.08
Cash from Financing 0.40

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 1,492 14,157 10.54
2024-07-25 1,483 9,296 15.95
2024-07-24 3,925 25,427 15.44
2024-07-23 7,207 32,854 21.94
2024-07-22 5,640 25,236 22.35

(click for more detail)

Similar Companies
LGVN – Longeveron Inc. LIPO – Lipella Pharmaceuticals Inc.
LIXT – Lixte Biotechnology Holdings, Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: Lipocine Inc